News
SPRC
0.3758
-9.55%
-0.0397
SciSparc registers to sell 76.81M ordinary shares for holders
TipRanks · 1d ago
SciSparc Ltd. Amends Form 6-K to Correct Floor Price to $0.11952
NASDAQ · 1d ago
Weekly Report: what happened at SPRC last week (1102-1106)?
Weekly Report · 1d ago
SciSparc Secures $2.55 Million Convertible Note Financing
TipRanks · 11/03 23:01
Weekly Report: what happened at SPRC last week (1026-1030)?
Weekly Report · 11/02 09:58
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 10/28 12:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 10/27 17:05
Nasdaq Gains Over 150 Points; Coca-Cola Posts Upbeat Earnings
Benzinga · 10/27 13:52
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/27 12:05
Why Celestica Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/27 08:53
SciSparc Ltd. Enters Inducement Agreement to Exercise Warrants for $405,728
NASDAQ · 10/26 20:32
SciSparc Secures $405,728 via Warrant Inducement Deal with L.I.A Pure Capital
TipRanks · 10/26 20:27
SciSparc Reduces Warrant Exercise Price To $1 Per Share In Inducement Agreement; Expects To Receive Aggregate Gross Proceeds Of ~$405,728 From Exercise Of Existing Warrants
Benzinga · 10/26 20:15
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 10/26 17:05
Dow Surges Over 200 Points; Verizon Shares Fall Following Q3 Results
Benzinga · 10/26 16:41
SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications
TipRanks · 10/26 13:00
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 10/26 12:05
Weekly Report: what happened at SPRC last week (1019-1023)?
Weekly Report · 10/26 09:58
Why Surgery Partners Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/26 09:13
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 10/23 21:05
More
Webull provides a variety of real-time SPRC stock news. You can receive the latest news about Scisparc through multiple platforms. This information may help you make smarter investment decisions.
About SPRC
Scisparc Ltd, formerly Therapix Biosciences Ltd, is an Israel-based pharmaceutical company committed to creating and enhancing technologies and assets based on cannabinoid pharmaceuticals. The Company is engaged in drug development programs based on repurposing cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), obstructive sleep apnea (OSA) and pain; THX-130 for the treatment of mild cognitive impairment (MCI) and traumatic brain injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.